Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors

被引：53

作者：

Zhang, Zhimin ^{[1
]}

Hou, Shaohua ^{[1
]}

Chen, Hongli ^{[1
]}

Ran, Ting ^{[2
]}

Jiang, Fei ^{[1
]}

Bian, Yuanyuan ^{[1
]}

Zhang, Dewei ^{[1
]}

Zhi, Yanle ^{[1
]}

Wang, Lu ^{[1
]}

Zhang, Li ^{[1
]}

Li, Hongmei ^{[1
]}

Zhang, Yanmin ^{[2
]}

Tang, Weifang ^{[1
]}

Lu, Tao ^{[2
,3
]}

Chen, Yadong ^{[2
]}

机构：

[1] Sch Sci, Dept Organ Chem, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China

[2] Sch Sci, Lab Mol Design & Drug Discovery, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China

[3] China Pharmaceut Univ, State Key Lab Nat Med, 24 Tongjiaxiang, Nanjing 210009, Jiangsu, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2016年 / 26卷 / 12期

基金：

中国国家自然科学基金;

关键词：

Epigenetic; Protein-protein interactions; Bromodomain; HDAC; Antiproliferative activity; BROMODOMAIN; DISCOVERY;

D O I：

10.1016/j.bmcl.2016.04.034

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The bromodomain protein module and histone deacetylase ( HDAC), which recognize and remove acetylated lysine, respectively, have emerged as important epigenetic therapeutic targets in cancer treatments. Herein we presented a novel design approach for cancer drug development by combination of bromodomain and HDAC inhibitory activity in one molecule. The designed compounds were synthesized which showed inhibitory activity against bromodomain 4 and HDAC1. The representative dual bromodomain/HDAC inhibitors, compound 11 and 12, showed potent antiproliferative activities against human leukaemia cell line K562 and MV4-11 in cellular assays. This work may lay the foundation for developing dual bromodomain/HDAC inhibitors as potential anticancer therapeutics. (C) 2016 Elsevier Ltd. All rights reserved.

引用

页码：2931 / 2935

页数：5

共 50 条

[41] Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors
Ibrahim, Tarek S.
Malebari, Azizah M.
Mohamed, Mamdouh F. A.
[J]. PHARMACEUTICALS, 2021, 14 (11)
[42] Synthesis and biological evaluation of benzoxepinoindol-1-one analogs as Brd4 bromodomain inhibitors
Jung, Goni
Lee, Joo-Youn
Park, Chi Hoon
Yoon, Eunyoung
Heo, Jung-Nyoung
[J]. BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2023, 44 (03) : 213 - 221
[43] Design, synthesis, and biological evaluation of quinazoline derivatives as dual HDAC1 and HDAC6 inhibitors for the treatment of cancer
Chen, Jinying
Sang, Zitai
Jiang, Youjun
Yang, Chao
He, Linhong
[J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 93 (03) : 232 - 241
[44] Rational design, synthesis and in vitro evaluation of allylidene hydrazinecarboximidamide derivatives as BACE-1 inhibitors
Jain, Priti
Wadhwa, Pankaj K.
Rohilla, Shilpa
Jadhav, Hemant R.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (01) : 33 - 37
[45] Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer's disease
He, Feng
Ran, Yingying
Li, Xiaoyang
Wang, Defeng
Zhang, Qiuqiong
Lv, Jiahui
Yu, Chenggong
Qu, Ying
Zhang, Xiangna
Xu, Ana
Wei, Chao
Chou, C. James
Wu, Jingde
[J]. BIOORGANIC CHEMISTRY, 2020, 103
[46] Design, synthesis and biological evaluation of novel 4,5-dihydro-[1,2,4] triazolo[4,3-f] pteridine derivatives as potential BRD4 inhibitors
Bi, Xinzhou
Li, Jieming
Li, Jiuhui
Shi, Wei
Dai, Yuxuan
Li, Qifei
Zhang, Wenjie
Huang, Wenlong
Qian, Hai
Jiang, Cheng
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (13) : 2813 - 2821
[47] Design, synthesis and biological evaluation of novel pyrazinone derivatives as PI3K/HDAC dual inhibitors
Wang, Zi-Xiao
Wang, Shuai
Qiao, Xue-Peng
Li, Wen-Bo
Shi, Jian-Tao
Wang, Yi-Ru
Chen, Shi-Wu
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 74
[48] Design, synthesis and biological evaluation of 7-methylimidazo[1,5-a] pyrazin-8(7H)-one derivatives as BRD4 inhibitors
Zhao, Leilei
Yang, Yifei
Guo, Yahui
Yang, Lingyun
Zhang, Jian
Zhou, Jinpei
Zhang, Huibin
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (08) : 2482 - 2490
[49] Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors
Chen, Chen
Hou, Xuben
Wang, Guohua
Pan, Wenyan
Yang, Xinying
Zhang, Yingkai
Fang, Hao
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 133 : 11 - 23
[50] Rational Design, Synthesis, In Vitro, and In Silico Studies of Dihydropyrimidinone Derivatives as β-Glucuronidase Inhibitors
Karimian, Somaye
Moghdani, Yasaman
Khoshneviszadeh, Mahsima
Pirhadi, Somayeh
Iraji, Aida
Khoshneviszadeh, Mehdi
[J]. JOURNAL OF CHEMISTRY, 2021, 2021

← 1 2 3 4 5 →